:

Saboor Saeed1, Huaizhi Wang2, Lingzhuo Kong3

  • 1Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Nanhu Brain-computer Interface Institute, Hangzhou, China; School of Medicine, Zhejiang University, Hangzhou, China.

PubMed
概括

双极性障碍 (BD) 患者患有较高的抑郁症状和较低的自由甲状腺素4 (FT4) 水平,面临自杀风险增加. 甲状腺自身免疫和T细胞免疫可能为个性化BD干预提供新的生物标志物.